Literature DB >> 21360297

Bioconjugated fluorescent polymeric nanoparticles for imaging and targeted therapy of HER2-overexpressing cancer cells.

Tzong-Der Way1, Chi-Jung Chang, Cheng-Wen Lin.   

Abstract

We report the development of Herceptin-conjugated fluorescent polymeric nanoparticles (PNp) probes. Synthesis of fluorescent conjugated polymer as the core, preparation of the core/shell PNp, the ability of immobilizing Herceptin on PNp, targeting and imaging of bioconjugated PNp toward HER2-overexpressing cancer cells, and therapeutic effect on cell cycle, together with the expression of apoptosis related proteins, were investigated. We have achieved active tumor targeting by rapid PNp-antibody binding to tumor-specific antigens. Besides, Herceptin-conjugated PNp can suppress the growth of HER2-overexpressing cancer cells. © Springer Science+Business Media, LLC 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21360297     DOI: 10.1007/s10895-011-0856-9

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  21 in total

1.  Evaluation of quantum dot cytotoxicity based on intracellular uptake.

Authors:  Emmanuel Chang; Nadhi Thekkek; William W Yu; Vicki L Colvin; Rebekah Drezek
Journal:  Small       Date:  2006-12       Impact factor: 13.281

Review 2.  Role of erbB2 in breast cancer chemosensitivity.

Authors:  D Yu; M C Hung
Journal:  Bioessays       Date:  2000-07       Impact factor: 4.345

3.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Authors:  D J Slamon; W Godolphin; L A Jones; J A Holt; S G Wong; D E Keith; W J Levin; S G Stuart; J Udove; A Ullrich
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

Review 4.  Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants.

Authors:  Vered Stearns; Bryan Schneider; N Lynn Henry; Daniel F Hayes; David A Flockhart
Journal:  Nat Rev Cancer       Date:  2006-10-12       Impact factor: 60.716

5.  Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.

Authors:  D Kirpotin; J W Park; K Hong; S Zalipsky; W L Li; P Carter; C C Benz; D Papahadjopoulos
Journal:  Biochemistry       Date:  1997-01-07       Impact factor: 3.162

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Tumor targeting by surface-modified protein microspheres.

Authors:  Farah Jean-Jacques Toublan; Stephen Boppart; Kenneth S Suslick
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

8.  Nanoparticle-based in vivo investigation on blood-brain barrier permeability following ischemia and reperfusion.

Authors:  Chung-Shi Yang; Chia-Hua Chang; Pi-Ju Tsai; Wen-Yin Chen; Fan-Gang Tseng; Leu-Wei Lo
Journal:  Anal Chem       Date:  2004-08-01       Impact factor: 6.986

9.  Anti-Her-2 monoclonal antibody conjugated polymer fluorescent nanoparticles probe for ovarian cancer imaging.

Authors:  Xu Hun; Zhujun Zhang; Liang Tiao
Journal:  Anal Chim Acta       Date:  2008-08-03       Impact factor: 6.558

10.  Conjugated polymers as molecular materials: how chain conformation and film morphology influence energy transfer and interchain interactions.

Authors:  Benjamin J Schwartz
Journal:  Annu Rev Phys Chem       Date:  2002-03-21       Impact factor: 12.703

View more
  4 in total

1.  A rhodamine-cyclen conjugate as chromogenic and fluorescent chemosensor for copper ion in aqueous media.

Authors:  Min Wang; Di Zhang; Man Li; Min Fan; Yong Ye; Yu-fen Zhao
Journal:  J Fluoresc       Date:  2013-01-16       Impact factor: 2.217

Review 2.  Strategies for Precise Engineering and Conjugation of Antibody Targeted-nanoparticles for Cancer Therapy.

Authors:  Yuan-Yuan Guo; Lu Huang; Zhi-Ping Zhang; De-Hao Fu
Journal:  Curr Med Sci       Date:  2020-07-17

3.  Folate conjugated chitosan grafted thiazole orange derivative with high targeting for early breast cancer cells diagnosis.

Authors:  Xue-Ning Fei; Yin Liu; Chao Li
Journal:  J Fluoresc       Date:  2012-06-30       Impact factor: 2.217

Review 4.  Nanomaterials for photo-based diagnostic and therapeutic applications.

Authors:  Jyothi U Menon; Parth Jadeja; Pranjali Tambe; Khanh Vu; Baohong Yuan; Kytai T Nguyen
Journal:  Theranostics       Date:  2013-02-20       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.